RAPT Therapeutics, Inc. (RAPT)
$58.01+0.00%Close
BUYBULL · day 28
Key stats
- Market cap
- $959M
- Avg volume
- 2.3M
- Beta
- 0.44
- P/E (TTM)
- -29.87
- 1W
- +0.05%
- 1M
- +0.40%
- 3M
- +80.77%
- YTD
- +82.14%
- vs SPY 1W
- +1.24%
- vs SPY 1M
- -2.92%
- vs SPY 3M
- +78.38%
- vs SPY YTD
- +70.38%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- APVOBUYAptevo Therapeutics Inc.CRISISQ -28$2.41-10.07%
- GANXBUYGain Therapeutics, Inc.RECOVERYQ -12$2.00-0.50%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -12$0.72+0.00%
- SNYRSELLSynergy CHC Corp.CRISISQ 1$0.10+0.00%
- IMCRBUYImmunocore Holdings plcRECOVERYQ 5$36.61-0.73%
- AKTSBUYAktis Oncology, Inc.Q 31$25.98+7.94%
- CTKBBUYCytek Biosciences, Inc.RECOVERYQ -10$4.44-7.69%
- HTFLBUYHeartflow, Inc. Common StockRECOVERYQ 46$50.20+0.90%
- KPRXBUYKiora Pharmaceuticals, Inc.RECOVERYQ -16$2.75+3.38%
- CELG-RIBUYBristol-Myers Squibb Company CeCRISISQ 8$0.10-16.67%
- ICCMSELLIceCure Medical LtdCRISISQ -19$2.27-6.58%
- GNPXSELLGenprex, Inc.CRISISQ -20$4.02+1.77%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.1%
REV YoY-
ROE-31.8%
EPS YoY-
ROA-31.6%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-29.87
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B10.29
P/FCF-
EV/EBITDA-17.86
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.71
ALTMAN Z-
CURR RATIO12.04
ND/EBITDA-
BETA0.44
Company news
Loading headlines…